登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及全体董事、监事、高级管理人员保证信息披露的内容真实、准确、完整、及时，没有虚假记 载、误导性陈述或重大遗漏。 经上海证券交易所审核同意，西安奕斯伟材料科技股份有限公司（以下简称"西安奕材""公司""本公 司"或"发行人"）发行的人民币普通股股票将于2025年10月28日在上海证券交易所科创板上市，上市公 告书全文和首次公开发行股票的招股说明书在上海证券交易所网站（http://www.sse.com.cn/）和符合中 国证监会规定条件网站（中国证券网，http://www.cnstock.com；中证网，http://www.cs.com.cn；证券时 报网，http://www.stcn.comx；证券日报网，http://www.zqrb.cn）披露，并置备于发行人、上交所、本次 发行保荐人（主承销商）中信证券股份有限公司的住所，供公众查阅。 一、上市概况 二、投资风险提示 根据《上海证券交易所科创板上市公司自律监管指引第5号一一科创成长层》，上市时未盈利的科创板 公司，自上市之日起纳入科创成长层。截至本公告披露日，西安奕材尚未盈利，自上市之日起将 ...

10月21日晚间，西安奕斯伟材料科技股份有限公司（证券简称"西安奕材"，证券代码688783）首次公开发行股票并在科创板上市的发行结果正式揭晓。 公告显示，西安奕材本次发行价格为8.62元/股,发行数量为5378万股,总计募集资金约46.36亿元，净额约为45.07亿元。发行工作顺利完成。 发行规模与市场热度双高，产业资本密集加持 西安奕材此次IPO是陕西省2025年迄今规模最大的IPO，募资金额更是跻身年内A股第二大IPO行列，仅次于华电新能。 另一方面，市场参与西安奕材新股发行热情高涨，近八成开通科创成长层权限的投资者参与网上认购。 更值得关注的是，国家集成电路产业投资基金（大基金二期）、陕西集成电路基金（由西安高新金控旗下西高投管理）等"国家队"及地方国企纷纷参与战 略配售，其中西高投作为公司"天使投资人"，截至发行前以9.06%持股稳居第三大股东，充分凸显产业资本对其长期价值的认可。 技术突破打破海外垄断，客户覆盖全球一线厂商 作为国内12英寸硅片领域的"硬科技"代表，西安奕材已构建起覆盖拉晶、成型、抛光、清洗、外延五大核心工艺的技术体系。 截至2025年6月末，公司已申请境内外专利合计1,843项， ...

格隆汇10月28日｜今日禾元生物(688765.SH)、必贝特(688759.SH)、西安奕材(688783.SH)、泰凯英 (920020.BJ)上市，德力佳(603092.SH)、中诚咨询(920003.BJ)申购。 ...

Core Viewpoint - The article highlights the significant growth and potential of Xi'an Yicai, a leading player in the 12-inch silicon wafer market, emphasizing its role in addressing China's semiconductor supply challenges and its recent IPO as a milestone in this journey [2][14]. Company Overview - Xi'an Yicai, founded by Wang Dongsheng, aims to become a competitive player in the semiconductor materials sector, leveraging his experience from BOE Technology Group [2]. - The company has achieved remarkable revenue growth, with sales increasing from 1.055 billion to 2.121 billion yuan over three years, reflecting a compound annual growth rate of approximately 42% [3][9]. Market Position - As of 2024, Xi'an Yicai ranks first in China and sixth globally in terms of 12-inch silicon wafer shipment volume and production capacity, holding approximately 6% of global shipment volume and 7% of production capacity [8][12]. - The company is a key supplier for major domestic storage IDM manufacturers and leading logic wafer foundries, establishing itself as a preferred partner for new 12-inch wafer plants [8][12]. Industry Trends - The semiconductor industry is entering an upward cycle driven by the growth of artificial intelligence and the recovery of the consumer electronics market, leading to increased demand for silicon wafers [6]. - Global production capacity for 12-inch wafers is projected to grow from 8.34 million wafers per month in 2024 to 10.64 million in 2027, with China's capacity expected to rise from 2.35 million to 3.53 million wafers per month [6]. Technological Advancements - Xi'an Yicai has developed a comprehensive core technology system covering all key processes in 12-inch wafer production, achieving competitive quality levels with the top five global manufacturers [10][12]. - The company has made significant technological breakthroughs, enabling its products to be used in advanced NAND Flash, DRAM, and logic chips, thus enhancing its product mix towards higher value segments [12][13]. Financial Performance - The company's net cash flow from operating activities has surged from 47 million yuan in 2022 to 815 million yuan in 2024, indicating strong market monetization capabilities [9]. - Xi'an Yicai's R&D investment has been substantial, with expenses increasing from 146 million yuan in 2022 to 128 million yuan in 2025, reflecting a commitment to innovation [10][13]. Future Prospects - The company plans to expand its production capacity to 1.2 million wafers per month by 2026, aiming to capture over 10% of the global 12-inch wafer market [14][17]. - The IPO proceeds will be used to fund the second phase of its silicon industry base project, which is expected to enhance its production capabilities significantly [15][17].

- The report tracks the recent IPO market performance, focusing on the net gains from new stock listings across the Sci-Tech Innovation Board, ChiNext, and Main Board, assuming all stocks are successfully subscribed and sold at the market average price on the first trading day, excluding lock-up restrictions[1][11][39] - The cumulative IPO net gains for A-class accounts with a scale of 2 billion reached 2.44%, while B-class accounts of the same scale achieved 2.19% as of October 24, 2025[11][39] - For larger accounts with a scale of 10 billion, the IPO net gains were significantly lower, with A-class accounts at 0.77% and B-class accounts at 0.70%[11][39] - The average first-day price increase for Sci-Tech Innovation Board stocks was 218.45%, while ChiNext stocks saw an average increase of 244.28%[1][16] - The report provides detailed calculations for theoretical IPO gains, using formulas such as: $ Full subscription quantity = Maximum subscription limit × Average offline subscription rate $ $ Full subscription gains = (First-day average price - IPO price) × Full subscription quantity $[35][39] - The highest full subscription gains among recent IPOs were achieved by United Power, Jindal Zhixin, and C Marco, with gains of 50.81, 12.58, and 11.03 million yuan respectively[35][38] - The report also includes monthly tracking of IPO gains for A-class accounts across different scales, showing a cumulative gain rate of 6.17% for 2 billion accounts since 2024, and 2.44% for 2025 alone[39][41] - Similar tracking for B-class accounts reveals a cumulative gain rate of 5.11% for 2 billion accounts since 2024, and 2.19% for 2025 alone[47][45] - The report highlights the IPO subscription process, including strategic placement, offline inquiry, and online pricing methods, with detailed statistics on subscription rates, oversubscription multiples, and effective subscription ratios for recent IPOs like Xi'an Yicai and Bibet[24][25]

Core Points - Three companies, Bibit (688759.SH), Heyuan Bio (688765.SH), and Xi'an Yicai (688783.SH), are set to be listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on October 28, marking the first batch of new listings since the launch of the Sci-Tech Growth Tier [1] - As of now, a total of 7.58 million investor accounts have opened trading permissions for the Sci-Tech Growth Tier, representing 126% of the active accounts among existing investors [1] - Following the release of the "1+6" policy reform for the Sci-Tech Board in June, 26 new companies have been accepted for listing, with 8 of them being unprofitable [1] - The first IPO application under the fifth set of listing standards, submitted by professional institutional investor Tianomaibo, was accepted on July 31 [1] - On September 26, the second IPO project under the restarted fifth set of listing standards, Anshi Bio, was accepted [1] - Companies such as Beixin Life, unprofitable company Moer Thread, and Angrui Micro have submitted registration on July 25, September 26, and October 15, respectively, under the fifth set of standards [1] - Unprofitable company Muxi Co. passed the listing committee review on October 24 [1]

证券研究报告 2025 年 10 月 27 日 星期一 【新股发行跟踪（20251027）】 一、上周新股表现情况 上周（10 月 20 日-10 月 24 日）共有 2 只新股上市，上市首日涨跌幅 均值为 263.20%。其中，有 2 只新股上市首日涨幅超 100%，为超颖电子、 马可波罗。 资料来源：东莞证券研究所，iFinD 二、周度新股上市情况走势 从周度新股上市规模来看，上周（10 月 20 日-10 月 24 日，下同）较 上上周（10 月 13 日-10 月 17 日，下同）相比，上市新股数量不变，首发 募资金额增加 15.91 亿元。 从周度上市新股表现来看，上上周无新股首日破发。 资料来源：东莞证券研究所，iFinD 本报告的风险等级为中高风险。 本报告的信息均来自已公开信息，关于信息的准确性与完整性，建议投资者谨慎判断，据此入市，风险自担。请务必阅读 末页声明。 1 表 1：上周新股表现 股票代码 股票简称 上市日期 上市 板块 发行价 格（元） 发行市 盈率 证监会行业 首日收盘 涨跌幅(%) 603175.SH 超颖电子 2025-10-24 主板 17.08 28.64 计算机、通信 ...

发行价格方面，今年已发行新股平均首发价格为20.93元，发行价在50元以上的有4家，发行价最高的是 天有为，发行价为93.50元，优优绿能、同宇新材次之，发行价分别为89.60元、84.00元，发行价较低的 有华电新能、天工股份等，首发价格分别为3.18元、3.94元。 地域分布来看，今年已发行新股主要集中在江苏、广东、浙江，分别有21家、16家、14家公司，募资金 额排名居前的分别是福建、广东、江苏，年内募资金额分别为181.71亿元、139.16亿元、135.67亿元。 （数据宝） 今年以来已发行新股 | 代码 | 简称 | 发行日期 | 发行总量（万股） | 发行价（元） | 募集资金（亿元） | | --- | --- | --- | --- | --- | --- | | 600930 | 华电新能 | 2025.07.07 | 571428.57 | 3.18 | 181.71 | | 688783 | 西安奕材 | 2025.10.16 | 53780.00 | 8.62 | 46.36 | | 603049 | 中策橡胶 | 2025.05.23 | 8744.86 | 46.50 | 40. ...

Group 1 - The new stock sector experienced a significant rebound last week, with an average increase of 4.9% since the beginning of 2024, and approximately 90.8% of new stocks achieving positive returns [1][13][30] - The short-term sentiment in the new stock market is expected to stabilize after a period of volatility, but the upcoming quarterly earnings reports may introduce performance disturbances [2][13] - The focus remains on sectors with stable earnings expectations, particularly in new energy, new consumption, and non-ferrous metals, while also tracking long-term investment themes such as robotics, AI, and innovative pharmaceuticals [3][13] Group 2 - Last week, two new stocks were listed, with an average first-day increase of 263%, indicating high trading enthusiasm despite some differentiation in performance [5][27] - The average first-day closing price-to-earnings ratio for new stocks in October has significantly increased to 106.4X, compared to 54.5X in the previous month, suggesting a rising trend in new stock pricing [18][20] - The upcoming week will see the listing of several new stocks, including He Yuan Biological and Xi'an Yicai, with an average issuance price-to-earnings ratio of 17.8X for new stocks expected to be listed [4][35][38]

Core Viewpoint - Gansu Shangfeng Cement Co., Ltd. has made significant progress in its semiconductor equity investments, with its invested companies achieving important milestones in their public offerings [1][2]. Group 1: Investment Progress - On October 23, the China Securities Regulatory Commission approved Beijing Angrui Microelectronics Technology Co., Ltd.'s initial public offering (IPO) registration, which is a company invested in by the Suzhou Industrial Park Chip Venture Capital Partnership, a fund established by Shangfeng Cement [1][2]. - Suzhou Chip holds 257,700 shares of Angrui Micro, representing a 0.35% stake prior to the public offering [2]. - Angrui Micro specializes in integrated circuit design, focusing on RF and analog fields, and is recognized as a national-level "little giant" enterprise [2]. Group 2: Fund Investments - The Zhongjin Material (Anhui) New Materials Industry Investment Fund, in which Shangfeng Cement invested 200 million yuan, has successfully completed the IPO of Xi'an Yiswei Material Technology Co., Ltd., raising approximately 4.636 billion yuan through the issuance of 538 million shares at a price of 8.62 yuan per share [2][3]. - The fund focuses on new materials, particularly inorganic non-metallic materials and composite materials, and has several projects nearing capitalization, including companies in fuel cell membranes and photolithography films [3]. Group 3: Strategic Development - Shangfeng Cement is leveraging a dual strategy of core business and equity investment to penetrate strategic emerging sectors such as semiconductors and new materials, which is expected to yield substantial investment returns and provide valuable experience for the company's industrial transformation and growth [3].